These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8085847)

  • 1. [Long-term administration of carmofur as a post-operative adjuvant chemotherapy for cervical adenocarcinoma. Cervical Adenocarcinoma Cooperative Research Association].
    Ikeda M; Teshima K; Noda K; Yamagata S; Sugawa T; Okamura S; Kubo H; Sugimoto O; Nakajima H; Yamabe T
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1967-74. PubMed ID: 8085847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of adjuvant chemotherapy with antimetabolites for cervical invasive cancer].
    Wada K; Koyama M; Iijima Y; Inagaki M; Hirota Y; Hongo J; Ozaki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):244-8. PubMed ID: 7699284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
    Lee HN; Lee KH; Lee DW; Lee YS; Park EK; Park JS
    Int J Gynecol Cancer; 2011 Jan; 21(1):128-36. PubMed ID: 21330837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postoperative simultaneous radiochemotherapy improves survival in patients with cervical carcinoma].
    Dunst J
    Strahlenther Onkol; 2000 Oct; 176(10):486-7. PubMed ID: 11068599
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III.
    Nakamura T; Ohno M; Tabuchi Y; Kamigaki T; Fujii H; Yamagishi H; Kuroda Y;
    Int J Oncol; 2001 Aug; 19(2):291-8. PubMed ID: 11445841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 8. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
    Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on effectiveness of carmofur (Mifurol) in urogenital carcinoma, especially bladder cancer, as a post-operative adjuvant chemotherapeutic agent].
    Nishio S; Kishimoto T; Maekawa M; Kawakita J; Morikawa Y; Funai K; Hayahara N; Yuki K; Nishijima T; Yasumoto R
    Hinyokika Kiyo; 1987 Feb; 33(2):295-303. PubMed ID: 3591594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study Group--third study on colorectal cancer.
    Ito K; Yamaguchi A; Miura K; Kato T; Baba S; Matsumoto S; Ishii M; Takagi H
    J Surg Oncol; 1996 Oct; 63(2):107-11. PubMed ID: 8888803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
    Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.
    McCaffrey R; Bahtiyar M; Kohorn EI; Chambers JT; Schwartz PE; Chambers SK
    Int J Gynecol Cancer; 2011 Apr; 21(3):535-44. PubMed ID: 21436702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of postoperative cervical cancer patients classified according to the risk for recurrence, and the effect of surgical adjuvant chemotherapy on the high risk group].
    Ueki M; Maeda T; Okamura S; Kanda T; Sano T; Sugimoto O
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):927-39. PubMed ID: 6619641
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Efficacy and Safety of Apatinib for the Treatment of Patients with Metastatic, Recurrent Cervical Cancer after Failure of Radiotherapy and First-Line Chemotherapy: A Prospective Study.
    Xia X; Jiang W; Qi W; Hong B; Zhao W
    Oncol Res Treat; 2020; 43(12):649-655. PubMed ID: 33045704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
    Hisamatsu T; Mabuchi S; Yoshino K; Fujita M; Enomoto T; Hamasaki T; Kimura T
    Int J Gynecol Cancer; 2012 May; 22(4):623-9. PubMed ID: 22343974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor prognosis in patients with adenosquamous cell carcinoma of the cervix.
    Gallup DG; Harper RH; Stock RJ
    Obstet Gynecol; 1985 Mar; 65(3):416-22. PubMed ID: 3974967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study.
    Ono T; Nagasue N; Kohno H; Hayashi T; Uchida M; Yukaya H; Yamanoi A
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-18-S6-25. PubMed ID: 9151912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
    Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
    J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
    Lee DW; Lee KH; Lee JW; Park ST; Park JS; Lee HN
    Int J Gynecol Cancer; 2013 Sep; 23(7):1303-10. PubMed ID: 23881101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.